COVID-19患者从诊断至1年随访的胸部CT表现
这项前瞻性研究纳入209例因COVID-19住院的患者,在症状出现后约3、7、12个月进行三次胸部CT纵向分析。结果显示,3个月时61%的患者CT异常完全吸收,12个月时达75%;1年时25%的患者仍有异常,其中13%表现为胸膜下网状或囊性病变。年龄≥50岁、淋巴细胞减少及重度或加重的ARDS是1年时CT异常残留的独立危险因素。
要点
- COVID-19后1年仍有25%患者胸部CT异常,13%为胸膜下网状或囊性病变。
- 年龄≥50岁、淋巴细胞减少、重度或加重ARDS是1年CT异常残留的独立危险因素。
- 出院时网状病变和支气管扩张在1年时分别有53%和45%持续存在。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The chest CT manifestations of COVID-19 from hospitalization to convalescence after 1 year are unknown. Purpose To assess chest CT manifestations of COVID-19 up to 1 year after symptom onset. Materials and Methods Patients were enrolled if they were admitted to the hospital because of COVID-19 and underwent CT during hospitalization at two isolation centers between January 27, 2020, and March 31, 2020. In a prospective study, three serial chest CT scans were obtained at approximately 3, 7, and 12 months after symptom onset and were longitudinally analyzed. The total CT score of pulmonary lobe involvement, ranging from 0 to 25, was assessed (score of 1-5 for each lobe). Univariable and multivariable logistic regression analyses were performed to explore independent risk factors for residual CT abnormalities after 1 year. Results A total of 209 study participants (mean age, 49 years ± 13 [standard deviation]; 116 women) were evaluated. CT abnormalities had resolved in 61% of participants (128 of 209) at 3 months and in 75% of participants (156 of 209) at 12 months. Among participants with chest CT abnormalities that had not resolved, there were residual linear opacities in 25 of the 209 participants (12%) and multifocal reticular or cystic lesions in 28 of the 209 participants (13%). Age 50 years or older, lymphopenia, and severe or aggravation of acute respiratory distress syndrome were independent risk factors for residual CT abnormalities at 1 year (odds ratios = 15.9, 18.9, and 43.9, respectively; P < .001 for each comparison). In 53 participants with residual CT abnormalities at 12 months, reticular lesions (41 of 53 participants [77%]) and bronchial dilation (39 of 53 participants [74%]) were observed at discharge and were persistent in 28 (53%) and 24 (45%) of the 53 participants, respectively. Conclusion One year after COVID-19 diagnosis, chest CT scans showed abnormal findings in 53 of the 209 study participants (25%), with 28 of the 209 participants (13%) showing subpleural reticular or cystic lesions. Older participants with severe COVID-19 or acute respiratory distress syndrome were more likely to develop lung sequelae that persisted at 1 year. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Lee and Wi et al in this issue.
引用
- Pan F, Yang L, Liang B, et al. Chest CT Patterns from Diagnosis to 1 Year of Follow-up in Patients with COVID-19. Radiology. 2021. PMID: 34609153. doi:10.1148/radiol.2021211199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。